OpGen, Inc. (OPGN)

Market Cap	11.68M
Revenue (ttm)	1.27M
Net Income (ttm)	-9.92M
Shares Out	10.07M
EPS (ttm)	-4.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Average Volume	10,059
Open	1.560
Previous Close	1.730
Day's Range	1.160 - 1.560
52-Week Range	0.527 - 9.900
Beta	-0.49
RSI	71.28
Earnings Date	Mar 24, 2025

About OpGen

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 93
• Stock Exchange: OTCMKTS
• Ticker Symbol: OPGN

Financial Performance

In 2023, OpGen's revenue was $3.42 million, an increase of 31.11% compared to the previous year's $2.61 million. Losses were -$32.67 million, -12.38% less than in 2022.